Covered recipient · General Payments record
KRISTOPHER RICHARD WOOD
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$2,374.94
- Reported across 153 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $469.08 | 30 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $155.54 | 13 |
| Novo Nordisk AS | $104.94 | 6 |
| GlaxoSmithKline, LLC. | $49.21 | 3 |
| Abbott Laboratories | $47.23 | 2 |
| Amgen Inc. | $43.95 | 2 |
| Lilly USA, LLC | $28.91 | 2 |
| Xeris Pharmaceuticals, Inc. | $23.23 | 1 |
| Acerta Pharma LLC | $16.07 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (30)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $23.34 | 02/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125209489 | CMS |
| Abbott Laboratories | $23.89 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125209491 | CMS |
| ABBVIE INC. | $15.42 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106357467 | CMS |
| ABBVIE INC. | $22.12 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106357469 | CMS |
| ABBVIE INC. | $23.81 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106357471 | CMS |
| ABBVIE INC. | $8.08 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106357473 | CMS |
| ABBVIE INC. | $6.43 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106357475 | CMS |
| ABBVIE INC. | $9.27 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106357477 | CMS |
| ABBVIE INC. | $4.12 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106357479 | CMS |
| ABBVIE INC. | $15.01 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106357481 | CMS |
| ABBVIE INC. | $9.51 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106357483 | CMS |
| ABBVIE INC. | $14.31 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106357485 | CMS |
| ABBVIE INC. | $10.10 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106357487 | CMS |
| ABBVIE INC. | $9.36 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106357489 | CMS |
| ABBVIE INC. | $8.00 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106357491 | CMS |
| Amgen Inc. | $22.82 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117418634 | CMS |
| Amgen Inc. | $21.13 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117418636 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.07 | 11/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105890686 | CMS |
| GlaxoSmithKline, LLC. | $13.08 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116404013 | CMS |
| GlaxoSmithKline, LLC. | $16.19 | 09/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115900725 | CMS |
| GlaxoSmithKline, LLC. | $19.94 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116439379 | CMS |
| Lilly USA, LLC | $14.73 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135137430 | CMS |
| Lilly USA, LLC | $14.18 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135112128 | CMS |
| Novo Nordisk Inc | $15.87 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096811024 | CMS |
| Novo Nordisk Inc | $16.46 | 04/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096960618 | CMS |
| Novo Nordisk Inc | $16.52 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096891519 | CMS |
| Novo Nordisk Inc | $13.14 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097188521 | CMS |
| Novo Nordisk Inc | $22.74 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096692280 | CMS |
| Novo Nordisk Inc | $20.21 | 11/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097209619 | CMS |
| Xeris Pharmaceuticals, Inc. | $23.23 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144602003 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.